Astral Limited has announced that its wholly owned subsidiary, Astral Chemie Limited, will acquire a 60 percent stake in Differentiated and Sustainable Solutions LLP (DSS) for ₹39.11 crore.
The transaction is expected to be completed on or before August 31, 2026, subject to customary closing conditions.
Once the deal is completed, DSS will become a direct subsidiary of Astral Chemie and a step-down subsidiary of the listed parent, Astral.
Shares of Astral traded between ₹1,498.50 and ₹1,531.30 during the session. The company has a market capitalisation of about ₹40,394 crore.
Deal structure
The acquisition has been structured as an all-cash transaction.
Key details of the deal:
- Stake being acquired: 60 percent
- Consideration: ₹39.11 crore
- Expected completion: On or before August 31, 2026
- Implied valuation of DSS: Around ₹65.18 crore
DSS has a manufacturing facility at Vilayat GIDC, Bharuch, Gujarat, with installed capacity of 5,200 MTPA.
Financial performance of DSS
The specialty chemicals company has reported the following turnover:
| Year | Revenue |
|---|---|
| FY24 | ₹1.44 crore |
| FY25 | ₹6.41 crore |
| FY26 (unaudited) | ₹3.21 crore |
Following completion of the transaction, Astral will consolidate DSS’s financials in its accounts, with adjustments for the 40 percent non-controlling interest.
Why the acquisition matters
The deal gives Astral access to technologies used in high-value specialty chemicals.
According to the company, DSS is the only domestic manufacturer with proprietary technology for certain chemical categories.
These include:
- Polyamines
- Bismaleimides
- Benzoxazines
These chemicals are used in:
- Epoxies
- Polyurethanes
- Industrial adhesives
The acquisition also supports Astral’s backward integration strategy for its adhesives and construction chemicals business.
Exposure to advanced industries
The products manufactured by DSS are used in several sectors.
These include:
- Aerospace
- Defence
- Electronics
- Renewable energy systems
The acquisition could help Astral strengthen its presence in high-margin industrial segments.
Balance sheet position
Astral’s financial metrics indicate a low level of leverage.
Key ratios:
- Current ratio: 1.85 times
- Debt-to-equity ratio: 0.05 times
- Return on equity (ROE): 17.5 percent
- Return on capital employed (ROCE): 22 percent
The company generates operating cash flows of more than ₹500 crore annually.
As a result, the ₹39.11 crore acquisition is not expected to require additional debt.
Areas investors may track
DSS’s revenue declined from ₹6.41 crore in FY25 to ₹3.21 crore in FY26.
The company appears to depend on uneven B2B order flows and long qualification cycles.
Investors may monitor:
- Capacity utilisation at the 5,200 MTPA facility.
- Integration of technology into Astral’s operations.
- Expansion into export markets such as:
- United States
- European Union
- Japan
About Astral
Founded in 1996, Astral Limited operates in construction materials and infrastructure solutions.
The company pioneered the introduction of CPVC pipe systems in India and has since diversified into adhesives and chemicals.
At the current market price of ₹1,504.20, Astral’s trailing twelve-month earnings per share stand at ₹19.97, translating into a P/E ratio of 73.3 times.
TL;DR
Astral Chemie, a wholly owned subsidiary of Astral, will acquire a 60 percent stake in specialty chemicals company DSS for ₹39.11 crore. The deal gives Astral access to proprietary technologies used in adhesives and advanced industrial applications.
AI summary
- Astral Chemie will buy a 60% stake in DSS for ₹39.11 crore.
- The transaction is expected to close by August 31, 2026.
- DSS operates a 5,200 MTPA facility in Bharuch, Gujarat.
- The acquisition supports Astral’s backward integration plans.
- DSS technologies are used in aerospace, electronics and renewable energy sectors.
